FEATURED
FINTECH
Insilico Medicine Convenes an Open Consortium For Benchmark Quality in AI-Driven Drug Discovery
Insider Brief Insilico Medicine launched the Open Drug Discovery and Development Consortium, or O3DC, to improve transparency around how computational drug-discovery benchmarks are evaluated and used. O3DC’s Benchmark…
Read briefing